EXACT Therapeutics minutes from Annual General Meeting June 12, 2026

12 Jun 2026 11:41 CEST

OSLO, 12 June 2026: EXACT Therapeutics AS (“EXACT-Tx”, “the Company” Euronext
Growth: EXTX) held its Annual General Meeting on June 12, 2026 at 10:30 CEST.

All proposed resolutions were approved.

Please find enclosed the minutes of the meeting including appendices. The
minutes will also be available on the company website: www.exact-tx.com



For more information, please contact:

Per Walday, CEO
EXACT Therapeutics
Email per.walday@exact-tx.com

John M. Edminson, CFO
EXACT Therapeutics
Email: john.edminson@exact-tx.com

About EXACT Therapeutics:
EXACT Therapeutics is a clinical-stage precision medicine company utilizing the
power of ultrasound to activate the proprietary drug PS101 and enhance the
clinical benefit of oncology therapies. PS101 has a unique mode of action and
may be combined with a wide range of therapeutic agents within oncology and
across a multitude of other indications, including brain diseases. EXACT
Therapeutics’ shares are traded on Euronext Growth Oslo (EXTX). Further
information may be found here: www.exact-tx.com

More information:
Access the news on Oslo Bors NewsWeb site

676062_EXACT_Therapeutics_AGM_2026_Minutes_Sign.pdf